Nel, ASA

Nel ASA: A Quiet August Hangs on Brussels While a New Product Line Fights the Cost Curve

Published on 08/14/2026 at 13:41 | Redaktion boerse-global.de

Nel ASA's quiet period precedes EU grant verdict; new PA-Series undercuts rivals at $1,450/kW, but revenue lags despite 224% order surge.

Nel ASA Awaits EU Grant Decision as PA-Series Targets Cost Barrier
Nel ASA: A Quiet August Hangs on Brussels While a New Product Line Fights the Cost Curve Illustration mit AI erstellt ĂĽbermittelt durch boerse-global.de

The Norwegian hydrogen equipment maker has entered an unusually subdued stretch. Since its second-quarter report roughly a month ago, Nel ASA has generated no fresh corporate announcements, no insider transactions and no analyst updates — a silence that has coincided with a 0.8 percent drift lower in the share price.

That calm could break in early August, when a decision is expected on an EU grant application under the HORIZON-JU-CLEANH2-2026 program. Nel and several partners have submitted bids, though no approval has been confirmed. For a company in a sector where state-backed demand remains a critical pillar, a positive outcome would signal that publicly funded appetite for electrolyzer technology persists despite a difficult market.

A New Platform With an Aggressive Price Point

The quiet news flow around the funding decision contrasts with the noise Nel generated in May, when it unveiled the PA-Series — a pressurized alkaline system designed to deliver turnkey costs of under $1,450 per kilowatt for 25-megawatt installations. That figure stands in stark relief against industry-standard systems, which market observers place at more than $3,000 per kilowatt.

The pricing strategy targets the industry's central bottleneck: capital expenditure decisions that have repeatedly stalled when industrial customers weigh the upfront cost of electrolysis capacity. Nel's positioning is a direct challenge to rivals in a market projected to expand at a compound annual growth rate of 24.2 percent through 2036, reaching $8.81 billion, according to market research that lists Nel among the leading suppliers.

Should investors sell immediately? Or is it worth buying Nel ASA?

Orders Are Up, Revenue Is Not

The timing of the product launch is no accident. Nel booked a sharp acceleration in order intake during the last quarter — a 224 percent surge — even as revenue declined, partly due to a settlement payment to Iwatani Corporation of America. A cheaper product could help convert that order momentum into actual sales without customers hesitating on cost.

The company's balance sheet provides some room to maneuver. Nel confirmed an order backlog of 1.2 billion Norwegian kroner and a cash position of roughly 1.3 billion kroner at the end of the second quarter. That liquidity gives management the runway to push the PA-Series into the market while the search for a new chief executive continues — the previous CEO's departure was announced alongside the quarterly results, but a successor has yet to be named.

Technical Signals Point Nowhere in Particular

The market has so far shrugged at the product news. The stock closed at €0.2025, down 2.2 percent on the day, though over the trailing seven sessions it has gained 1.6 percent — a picture of indecision rather than conviction. The shares currently trade at €0.1984, about 5.7 percent below their 50-day average of €0.2104, suggesting a soft short-term trend. The relative strength index sits at 43.7, a neutral reading that reflects a market waiting for direction.

That wait carries risk. For a company that posted an operating loss on an EBITDA basis in the last quarter and still needs to convert its backlog into revenue, any delay in funding decisions or project approvals complicates liquidity planning. The leadership vacuum adds another layer of uncertainty.

What to Watch in the Weeks Ahead

Investors are left with two open questions. First, will the EU funding decision arrive on schedule and favor Nel and its partners? Second, how quickly will the board fill the top executive role?

Until either is resolved, the stock may anchor to technical levels. The 52-week low of €0.1731 sits about 15 percent below the current price and could serve as the next support if sentiment sours. With a market capitalization of roughly €376 million, Nel's valuation leaves little margin for error — the funding verdict and the succession process will likely set the trading range for the coming weeks, independent of the operational story, which already raises enough questions with its strong order intake and declining revenue.

Ad

Nel ASA Stock: New Analysis - 14 August

Fresh Nel ASA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Nel ASA analysis...

Disclaimer...

en | NO0010081235 | NEL | boerse | 69948965 |